Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1314 of 5804
-
Can a phone app curb HIV and drug use in homeless teens?
Prevention Recruiting nowThe purpose of this study is to determine whether Motivating Youth to Reduce Infections, Disconnections, and Emotion dysregulation (MY-RIDE) decreases substance use , to determine whether MY-RIDE increases human immunodeficiency virus (HIV) prevention strategies and to evaluate M…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
New radiation technique aims to shrink spine tumors with fewer side effects
Symptom relief Recruiting nowTo learn about the safety of a procedure called cord dose escalated spine stereotactic radiosurgery (CDE-SSRS) in patients with MESCC.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New strategy aims to boost HIV viral suppression in young people
Disease control Recruiting nowAlthough there have been advances in antiretroviral treatment (ART) for HIV, adolescents and young adults living with HIV (AHIV) continue to have disparate HIV outcomes particularly viral suppression (VS), when compared to other populations likely related to multi-layered challen…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study tracks bone safety of DMD drug vamorolone over years
Disease control OngoingThis study aims to assess safety and effectivness of long-term treatment with vamorolone in boys with Duchenne Muscular Dystrophy (DMD) who have completed prior studies with vamorolone.
Phase: PHASE4 • Sponsor: Santhera Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Bladder drug repurposed to fight ALS in new trial
Disease control Recruiting nowAmyotrophic lateral sclerosis (ALS) is a progressive neurological disorder characterized by selective death of upper and lower motor neurons, which leads to severe disability and fatal outcomes. One of the major hallmarks of ALS is the denervation of neuromuscular junctions (NMJs…
Phase: PHASE2 • Sponsor: Oliver Blanchard • Aim: Disease control
Last updated Jun 26, 2026 14:18 UTC
-
New 'Smart' immune therapy takes on lupus and arthritis
Disease control Recruiting nowThis study is an open-label, multiple-dose escalation, Investigator-Initiated Trial (IIT) clinical trial designed to evaluate the safety and tolerability of CC312 in adult patients with relapsed and refractory autoimmune diseases. The trial also assesses pharmacokinetics (PK) and…
Phase: EARLY_PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated Jun 26, 2026 18:43 UTC
-
New cancer drug M3554 targets tough tumors in first human trial
Disease control Recruiting nowThe purpose of this study is to establish the recommended doses and further evaluate the safety and preliminary antitumor activity of M3554 in participants with soft tissue sarcoma (STS) and glioblastoma, IDH-wildtype. Study details include: Study Duration per participant: Appr…
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New combo aims to boost existing cancer Drug's power
Disease control Recruiting nowResearchers are looking for a better way to treat people who have advanced solid cancers with a KRASG12C mutation. Sotorasib is a drug that targets cancer cells which contain mutated KRASG12C protein; it can stop the cancer cells from growing and can lead to their death. Sotoras…
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New study aims to shield transplant patients from deadly fungal infections
Disease control Recruiting nowPatients receiving an allogeneic hematopoietic stem cell transplant (allo-CSH) are at high risk of infection, particularly of fungal origin. Until the 2018 recommendations of the 6th European Conference on Infections in Leukemia (ECIL6), primary prophylaxis of invasive fungal inf…
Phase: PHASE2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
AI reads your Heart's electrical signals to spot hidden valve trouble
Diagnosis Recruiting nowTwo recently developed artificial intelligence-enabled electrocardiogram (AI-ECG) models have been developed to detect aortic stenosis (AS) and diastolic dysfunction (DD). AI-ECG for AS has a sensitivity of 78% and specificity of 74%, and AI-ECG for DD has a sensitivity of 83% an…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
New hope for rare cancer: targeted drug afatinib tested in fanconi anemia patients
Disease control Recruiting nowThis research study is a phase Ib/II, single-arm, non-randomized, non-blind, multicenter study designed to determine whether Afatinib is effective and safe in patients with locoregionally unresectable and / or metastatic HNSCC with Fanconi Anemia. The main hypothesis, based on p…
Phase: PHASE1, PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New study tests two programs to stop child abuse before it starts
Prevention ENROLLING_BY_INVITATIONChild maltreatment and child exposure to adult intimate partner violence (IPV) often co-occur and are detrimental to the mental and physical health of children, yet few prevention programs address these intersecting forms of adversity using dual-generation approaches. The propose…
Phase: PHASE2 • Sponsor: University of Notre Dame • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
New diabetes drug shows promise in Mid-Stage trial
Disease control OngoingThe main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
App aims to curb suicide risk in ERs – 28,000 patients enrolled
Disease control ENROLLING_BY_INVITATIONThis Study will evaluate the implementation of a multi-component suicide prevention technology (Jaspr Health) that facilitates delivery of suicided-related evidence-based practices (EBPs) while replacing wasted waiting time with productive time in the Emergency Departments (EDs).…
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New immune drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowPhase 1 First-in-human study of the safety and efficacy of IMC-P115C as a single agent and in combination with standard of care (SOC) agents in participants with advanced PRAME positive cancers. IMC-P115C is a half-life extended (HLE) ImmTAC targeting PRAME.
Phase: PHASE1 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New network aims to stop HIV in latino men
Prevention Recruiting nowThe objective of this study is to evaluate the JUNTOS Referral Network as an implementation strategy to enhance the reach of HIV-prevention and treatment services to Latino gay, bisexual, and other men who have sex with men (MSM).
Phase: NA • Sponsor: University of Miami • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Experimental drug aims to rebuild immune defenses in rare disorder
Disease control Recruiting nowBackground: Idiopathic CD4 lymphopenia (ICL) is a syndrome characterized by low levels of certain immune cells called CD4 T cells. The low CD4 T cells renders people with ICL prone to many types of severe infections, autoimmune diseases, and cancers. Although these infections an…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New trial tests antibiotic to cut C-Section infections
Disease control Recruiting nowThis is a phase-III multi-center double-blind randomized controlled trial of 8,000 individuals undergoing a scheduled or prelabor cesarean delivery who are randomized to either adjunctive azithromycin prophylaxis or to placebo. Both groups also will receive standard of care preop…
Phase: PHASE3 • Sponsor: The George Washington University Biostatistics Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
One-Day liver cancer treatment could cut hospital time in half
Disease control ENROLLING_BY_INVITATIONThis single-arm feasibility study evaluating the safety and efficacy of streamlining Yttrium-90 (Y90) radioembolization workflow for patients with small Hepatocellular Carcinoma (\<5cm) that have no aggressive features on baseline imaging. This study aims to recruit N=30 patie…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New balloon catheter zaps heart rhythm problem in early trial
Disease control OngoingThis clinical trial aims to evaluate the safety and effectiveness of pulmonary vein isolation (PVI) and linear ablation using a large-focal pulsed field ablation (PFA) catheter in patients with persistent atrial fibrillation (perAF). The study will address two primary questions: …
Phase: NA • Sponsor: The Third People's Hospital of Chengdu • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC